Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the Third quarter of 2019 at the end of 30th September 2019 as
results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
Microsoft Word - MD_A_Q3_2019_EN 1 GLOCON.061/2019 November 11th, 2019 Subject Management’s analysis for the 3rd quarter of 2019 Attn. The President The Stock Exchange of Thailand Management’s
Page 1 No. CMC Sor Lor.013/2019 Date 12 November 2019 Re: Management Discussion & Analysis for the Period Ended 30 September 2019 To The President of the Stock Exchange of Thailand (SET
กัด 57,367.16 13.78 CGS-CIMB SECURITIES (THAILAND) COMPANY LIMITED 3 โนมูระ พัฒนสิน จํากัด (มหาชน) 52,937.34 12.71 CAPITAL NOMURA SECURITIES PUBLIC COMPANY LIMITED 4 ไทยพาณิชย จํากัด 51,375.72 12.34
11.62 CLSA Securities (Thailand) Ltd. 5 เคจีไอ (ประเทศไทย) จํากัด (มหาชน) 16,272.75 7.24 KGI SECURITIES (THAILAND) PUBLIC COMPANY LIMITED 6 อารเอชบี (ประเทศไทย) จํากัด (มหาชน) 16,086.00 7.15 RHB
Page 1 of 2 AC6305/006 May 14, 2020 Subject Clarification of the operating results for the quarter 1/2020 ended March 31, 2020 To Director/ Managing Director The Stock Exchange of Thailand According
Thai CG × Home > Archive > การกำกับดูแลกิจการที่ดี / ความยั่งยืน CG Thailand แนวคิด การกำกับดูแลกิจการ
No. ACC6311/010 12 November, 2020 Subject Clarify the Operating results for quarter 3/2020 ended 30 September, 2020 Attention Director and Manager The Stock Exchange of Thailand According to Advanced
Ref: ACC6405/001 March 12, 2021 Subject Clarification of the operating results for the quarter 1/2021 ended March 31, 2021 Attention: Director and Manager The Stock Exchange of Thailand According to